Full text is available at the source.
Abstract
Loss-of-function mutations in TBK1 are linked to ALS and FTD through impaired TDP-43 clearance.
- A novel proteostatic pathway involving TBK1 and the immunoproteasome regulates the clearance of TDP-43.
- TBK1 is activated by aggregated TDP-43, which helps reduce TDP-43 pathology in neuronal cells.
- Activation of TBK1 leads to increased expression of IFNβ, enhancing the degradation of TDP-43 in neurons.
- Reduced expression of the IFNβ receptor is observed in spinal motor neurons from ALS patients exhibiting TDP-43 pathology.
- In SOD1G93A mice, deletion of one Tbk1 gene impairs the induction of the immunoproteasome and increases protein accumulation in the spinal cord.
Simplified